DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Trisenox (Arsenic Trioxide) - Febrile Neutropenia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Febrile Neutropenia (3)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Trisenox (Arsenic Trioxide) where reactions include febrile neutropenia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Trisenox side effects in 5 year old female

Reported by a physician from United States on 2012-05-29

Patient: 5 year old female, weighing 21.4 kg (47.1 pounds)

Reactions: White Blood Cell Count Decreased, Bacterial Infection, Febrile Neutropenia, Endocarditis, Platelet Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mitoxantrone
    Indication: Acute Promyelocytic Leukaemia
    Start date: 2011-12-19

Trisenox
    Indication: Acute Promyelocytic Leukaemia
    Start date: 2012-04-13

Cytarabine
    Indication: Acute Promyelocytic Leukaemia
    Start date: 2011-12-19

Cytarabine
    Dosage: high dose
    Start date: 2012-04-25

Tretinoin
    Indication: Acute Promyelocytic Leukaemia
    Start date: 2011-12-19



Possible Trisenox side effects in female

Reported by a physician from United States on 2011-12-28

Patient: female, weighing 56.0 kg (123.2 pounds)

Reactions: Febrile Neutropenia, Escherichia Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Trisenox
    Start date: 2011-09-12
    End date: 2011-10-14

Cytarabine

Mitoxantrone Hydrochloride

Cytarabine

Tretinoin

Trisenox
    Indication: Acute Promyelocytic Leukaemia
    Start date: 2011-07-27
    End date: 2011-08-26



Possible Trisenox side effects in female

Reported by a physician from United States on 2011-11-18

Patient: female, weighing 56.0 kg (123.2 pounds)

Reactions: Febrile Neutropenia, Escherichia Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine

Trisenox
    Indication: Acute Promyelocytic Leukaemia
    Start date: 2011-07-27
    End date: 2011-08-26

Trisenox
    Start date: 2011-09-12
    End date: 2011-10-14

Cytarabine

Tretinoin

Mitoxantrone Hydrochloride

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017